Oxybutynin Chloride Tablet
Product Images NDC 71335-1494

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 71335-1494). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structural Formula (Figure 1 Structure)

Structural Formula (Figure 1 Structure)
Chemical structure of oxybutynin chloride showing its molecular arrangement with various functional groups and the hydrochloride component.*
FDA Label Image

Table 1 (Figure 2 Table1)

Table 1 (Figure 2 Table1)
A table comparing pharmacokinetic parameters of R-Oxybutynin and S-Oxybutynin, including Cmax (ng/mL), Tmax (hours), AUCt (ng•h/mL), and AUCinf (ng•h/mL), with mean values and standard deviations shown for each parameter.*
FDA Label Image

Figure 1 (Figure 3 Figure1)

Figure 1 (Figure 3 Figure1)
A line graph showing mean plasma concentration of R-Oxybutynin (ng/mL) over a 24-hour period following administration of Oxybutynin 5 mg TID. The x-axis represents time in hours, and the y-axis represents concentration levels. Data points with error bars indicate variability at each time point.*
FDA Label Image

Table 2 (Figure 4 Table2)

Table 2 (Figure 4 Table2)
A data table presenting pharmacokinetic parameters of four compounds: R-Oxybutynin, S-Oxybutynin, R-Desethyloxybutynynin, and S-Desethyloxybutynynin. The table lists Cmax (ng/mL), Tmax (hr), and AUC (ng·hr/mL) values with associated standard deviations for each compound, reflecting pooled data and dosing interval information.*
FDA Label Image

Figure 2 (Figure 5 Figure2)

Figure 2 (Figure 5 Figure2)
A line graph showing mean R-Oxybutynin plasma concentration (ng/mL) versus time (hours) over a 12-hour period. Data points with error bars indicate concentration changes at various times, starting low at 0 hours, peaking around 1 hour, and gradually declining through 12 hours.*
FDA Label Image

Table 3 (Figure 6 Table3)

Table 3 (Figure 6 Table3)
A data table listing adverse events by body system associated with oxybutynin chloride at doses of 5-20 mg/day in a study with 199 subjects. It includes percentages for urinary tract infection, insomnia, nervousness, dizziness, somnolence, headache, blurred vision, dry mouth, constipation, nausea, dyspepsia, urinary hesitation, and urinary retention.*
FDA Label Image
Kvk Logo (Figure 7 Company Logo)
FDA Label Image

Label Image (Lbl713351494)

Label Image (Lbl713351494)
Oxybutynin Chloride 5 mg oral tablet label by Bryant Ranch Prepack. The label includes instructions to keep in a light-resistant container and store at room temperature between 20°-25°C (68°-77°F). It also references a comparator product, Ditropan 5 mg tablet from KVK-TECH, INC. The label indicates a quantity of 30 tablets and displays a lot number and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.